Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk

Journal of Clinical Oncology - United States
doi 10.1200/jco.18.01412
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Who Gets Genomic Testing for Breast Cancer Recurrence Risk?

Public Health Genomics
EnvironmentalPublic HealthGeneticsOccupational Health
2013English

Overview on the Role of Breast Conservative Treatments for Early Breast Cancer With Low Risk of Recurrence: History, Standard and Controversies

2019English

Genome-Based Risk Prediction for Early Stage Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2014English

MINDACT Study Results Show Low Risk of Local Recurrence After 5 Years for Patients With Early Breast Cancer

Cancer
Cancer ResearchOncology
2018English

Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer

Breast Cancer: Basic and Clinical Research
Cancer ResearchOncology
2016English

PAM50 and Risk of Recurrence Scores for Interval Breast Cancers

Cancer Prevention Research
MedicineCancer ResearchOncology
2018English

Body Size in Early Life and Risk of Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2017English

Influence of Competing Risks on Estimates of Recurrence Risk and Breast Cancer-Specific Mortality in Analyses of the Early Breast Cancer Trialists Collaborative Group

Scientific Reports
Multidisciplinary
2020English

Do Phytoestrogens Reduce the Risk of Breast Cancer and Breast Cancer Recurrence? What Clinicians Need to Know

European Journal of Cancer
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy